Breast Cancer Specialization

CERTIFICATION

Master in Breast Pathology Senology issued as UB-specific degree.

DURATION

Nov 2020 – Jun 30 2021

LANGUAGE

Spanish
Some lessons may be in English

OBJECTIVE TARGET

Gynaecologists, surgeons, pathologists, radiologists and oncologists.

ENROLLMENT PERIOD

From Sep 7 2020 to Oct 30 2020

FORMAT

Online the first year
On-site the second year

Direction

Director: Aleix Prat Aparicio
Co-directors: Miquel Prats de Puig and Edelmiro Iglesias Martínez

COST

First year: 2,850€; Second year: 3,150€ (Increase of 10% to the amount, up to a maximum of 70€, in terms of administrative fees).

NUMBER OF PLACES

Limited

CREDITS

65 ECTS

ACCESS REQUIREMENTS

Degree in Medicine or Nursing

Master in Senology is a UB-specific degree from the Medicine Faculty and consists of two courses: one theoretical and one practical.

Specialization in Breast Cancer is intended to give a specific training in breast cancer, from a knowledge about its molecular biology, development and use of biomarkers and clinic research, to the diagnosis and treatment of localized and advanced breast cancer.

Even accepting that it is possible to know totally or partially the program and that some lessons may be of greater or lesser interest depending on the specialty, attendance and participation in all the master’s activities will be required, and passing evaluations, without contemplating the validation of other studies, knowledge accreditation, welfare efforts, etc.

The master is composed of two academic courses, which form a total of 65 academic credits ECTS (1ECTS = 25 class hours).
– 1st year: 30 credits ECTS.
– 2nd year: 35 credits ECTS.

1st YEAR
Module 1: MOLECULAR BIOLOGY
Module 2: EARLY BREAST CANCER
Module 3: METASTATIC BREAST CANCER
2nd YEAR
Module 4: CASE STUDIES
Module 5: EXTERNAL ROTATIONS
Module 6: MASTER FINAL PROJECT

Alexis Rodríguez Gallego

Clinical Pharmacology specialist

Clinical Pharmacology specialist. He has a master’s degree in Bioethics and Law and is a member of the CEIm (Comité de Ética de Investigación con medicamentos) of the Hospital Vall d’Hebrón in Barcelona.

Atanasio Pandiella

Professor of Research at the Centro de Investigación del Cáncer of Salamanca.

His training includes research at the CNR, Ospedale San Raffaele in Milán and the Memorial Sloan Kettering Cancer Center in New York. His research focuses on the functional characterization of molecules involved in different human solid tumors, in particular breast tumors.

Ana Janic

Group Leader at Universidad Pompeu Fabra

Graduated from the University of Belgrade and PhD in Biomedicine from IRB-Barcelona. She is currently Professor Tenure-Track at the Universidad Pompeu Fabra of Barcelona, where she studies how tumor suppressors protect us from the development of cancer.

Oriol Casanovas

Group Leader at IBIDELL

Researcher of recognized international prestige with extensive knowledge and experience in basic and translational research of murine models of cancer and tumor angiogenesis. His scientific studies have been published in highly regarded journals in the cancer field.

Aranzazu Fernández

Medical Oncologist

Post-doctoral research associate in the laboratory run by Charles M.Perou at the UNC Lineberg Comprehensive Cancer Center. Her research interest is focused on Breast Cancer Genomic Biomarkers.

Violeta Serra

Group Leader of the VHIO Experimental Therapies Group

PhD from the University of Newcastle and postdoctoral stays in Charité, Berulon and CNIO. She is currently the principal investigator of the VHIO Experimental Therapies Group, where she studies the identification of biomarkers response to targeted therapies in breast cancer.

José Rios

Coordinator of the Medical Statistics Platform of IDIBAPS-Hospital Clínic of Barcelona.

More than 25 years of experience in statistical-methodological support with more than 200 indexed papers. He currently coordinates the medical statistical platform of IDIBAPS-Hospital Clínic and is an associate professor at the Faculty of Medicine of the UAB. He also collaborates with independent research groups like SOLTI.

Dolors Soy Muner

Head of Pharmacy at Hospital Clínic

PhD in Pharmacy from the Universidad de Barcelona and specialist in Hospital Pharmacy. She is an associate professor at the Faculty of Pharmacy of the Universidad de Barcelona while continuing her research. Her main lines of research focus on knowledge of the dose-concentration-effect relationships of drugs.

Orland Diez

Senior Researcher of the Hereditary Cancer Group of VHIO

PhD in Biology, physician at the Clinical and Molecular Genetics Area of the Hospital Universitario Vall d’Hebron and Senior Researcher of the Hereditary Cancer Group of the Vall d’Hebron Instituto Oncológico (VHIO).

Manel Esteller

Director of the Instituto de Investigación contra la Leucemia Josep Carreras

PhD of Medicine and Surgery from the Universidad de Barcelona. He is currently Director of the Instituto de Investigación contra la Leucemia Josep Carreras (IJC), research professor at ICREA and Tenured Full Professor of genetics at the School of Medicine of the Universidad de Barcelona. Author of more than 500 scientific publications and awarded among others with the Severo Ochoa Award and the Genetics and Oncology National Awards. His research focuses on the epigenetic mechanisms responsible for human disease, mainly cancer.

Patricia Villagrasa

Scientific Director of the Grupo Académico de Investigación Clínica y Traslacional en Cáncer SOLTI.

PhD in Molecular Biology and Biochemistry from the Universidad Autónoma de Barcelona. After more than 10 years in cancer research, she joined SOLTI in 2013 after a postdoctoral period at Columbia University (New York, USA) focused on breast cancer. Currently, she is the Scientific Director of the Grupo Académico de Investigación Clínica y Traslacional en Cáncer SOLTI, where she coordinates all operations and the scientific team, which supports the design and management of clinical trials for all researchers in the group.

Oscar Salamanca

Managing Director of APICES

Pharmacist and MBA from the Instituto de Empresa. With more than 25 years of experience in the drug research and development sector and with extensive management experience in the field of clinical research in CROs (Contract Research Organizations) and in the Oncology area. He is currently Managing Director of APICES (European CRO).

Judith Balmaña

Group Leader of the Hereditary Cancer Genetics Group in the Medical Oncology Service at VHIO

She specialized as a medical oncologist and is currently Head of the Hereditary Cancer Genetics Group in the Medical Oncology Service at the Hospital Universitario Vall d’Hebron and at the Vall d’Hebron Insitut d’Oncologia (VHIO). Her research areas cover the genetic epidemiology of hereditary breast and ovarian cancer, the clinical and psychological impact of genetic testing, and the clinical development of targeted therapies for patients with hereditary breast cancer.

Claudia Arnedo

PhD student at the Biomedical Genomics laboratory (IRB)

Graduated in Biomedical Sciences from the Universidad de Barcelona. In 2018, she obtained a Master's degree in Bioinformatics for Health Sciences from the Universidad Pompeu Fabra. She is currently carrying out her doctoral thesis in the Biomedical Genomics laboratory (IRB), led by Dr. Núria López Bigas, studying cancer driver mutations.

Toni Hurtado

Researcher at the Biosciences Department, Faculty of Medicine (University of Barcelona)

PhD at the Vall d’Hebron Institut de Recerca In late 2011, he became a group leader at the Norwegian Center for Molecular Medicine. He recently joined the Department of Biosciences at the Faculty of Medicine (Universidad de Barcelona), where he has focused on investigating the mechanisms related to the response to anti-ER drugs in breast tumors growth.

Dr. Aleix Prat Aparicio

Master in Breast Pathology and Breast Cancer co-director.

Bachelor of Medicine from the University of Barcelona PhD from the Universidad Autónoma de Barcelona. Master in Molecular Oncology at the Centro Nacional de Investigaciones Oncológicas (CNIO). PostDoctoral fellowship at the University of North Carolina, USA.

Dr. Miguel Prats de Puig

Master in Breast Pathology and Breast Cancer co-director.

Renowned gynecologist specialist with extensive experience in senology- breast pathology. He has completed training stays in highly prestigious breast pathology units, both nationally and internationally. He has extensive surgical training in benign and malignant processes of the breast, including techniques as selective biopsy of the sentinel lymph node and intraoperative breast ultrasound. He is a pioneer and a reference in Spain in breast surgery with intraoperative radiation therapy. In addition to clinical practice, he also teaches at different universities and is the author of various chapters in books on breast pathology. Furthermore, he is a member of the main medical societies of his specialty at an international level.

Edelmiro Iglesias Martínez

Master in Breast Pathology and Breast Cancer co-director.

Specialist in General Surgery and expert in breast pathology. In addition to teaching, he is Co-director of the Master's Degree in Breast Pathology and Breast Cancer at the Universidad de Barcelona and Director of the University Specialist Course in Senology for Nurses at the Universidad de Lleida. He is the author of more than 100 articles and communications in scientific journals and conferences. He is also a member of various medical societies, including the coordinator of the Accreditation Committee of the Unidad de Mama de la Sociedad Española de Senología y Patología Mamaria (SESPM) and Vice President of this same society.

MORE INFORMATION ADMISSION